Nuptials Called Off by Skyworks & PMC Sierra. Ebola Vax? FDA Panel Drives Biotech Again

Skyworks (@NASDAQ: $SWKS) & PMC Sierra (@NASDAQ: $PMCS) call off their merger as Skyworks declines to raise their offer price again, and PMC Sierra shells out an $88 million break-up fee. Several FDA approvals and a handful of denials colors the biotech landscape; Emergent Biosolutions (@NYSE: $EBS) receives approval for its Anthrax drug. Ebola outbreak in Sierra Leone highlights the development efforts of the FDA and a consortium of private sector biopharma companies such as small cap Inovio (@NASDAQ: $INO) to fast-track a vaccine.

Видео Nuptials Called Off by Skyworks & PMC Sierra. Ebola Vax? FDA Panel Drives Biotech Again автора Интерьеры с природным настроением и эстетикой